In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 3

Thermo Fisher Scientific, Inc. - Shareholder/Analyst Call

Thermo Fisher Scientific Inc. (TMO) May 22, 2013 9:00 am ET Executives Kenneth J. Apicerno - Vice President of Investor Relations and Treasurer Marc N. Casper - Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee Peter M. Wilver - Chief Financial Officer and Senior Vice President Alan J. Malus - Executive Vi...

Biomarker Predicts Organ Rejection and Death in Heart Transplant Patients

Critical Diagnostics’ novel cardiac biomarker, ST2, could offer a way for doctors to monitor transplant patients versus expensive and risky biopsies Critical Diagnostics announced today the recently-published results of a Utah Transplantation Affiliated Hospitals Cardiac Transplant Program study involving the use of a novel biomarker, ST2, to monitor...

Mayo Clinic Forms Joint Venture with Cancer Genetics

OncoSpire Genomics will seek to discover and commercialize biomarkers for multiple cancer types Mayo Clinic ("Mayo") and Cancer Genetics Inc. (OTCQB: CGIX) today launched OncoSpire Genomics ("OncoSpire"), a joint venture with the singular goal of improving cancer care by discovering and commercializing diagnostic tests that leverage

Perosphere Receives FDA IND Clearance to Initiate Clinical Investigations of the Safety and Efficacy of PER977 to Reverse the Activity of Anticoagulation Therapies including Factor Xa- and IIa-Inhibitors

Clearance also includes Clinical Investigation of PER977 to Reverse the Anticoagulation Activity of Unfractionated Heparin, Low Molecular Weight Heparins, and Fondaparinux Perosphere Inc. announced today that it has received U.S. Food and Drug Administration ("FDA") Investigational New Drug ("IND") clearance to initiate clinical investigations of the s...

Roche presents new, fully automated lab solution at Europe’s largest diagnostics conference

System improves efficiency and speed of blood sample testing in medical labs...

Abbott Laboratories' Management Presents at UBS Global Healthcare Conference (Transcript)

Abbott Laboratories (ABT) UBS Global Healthcare Conference Call May 22, 2013, 8:30 am ET Executives Brian Blaser - Executive Vice President - Diagnostics Products Thomas Freyman - Chief Financial Officer, Executive Vice President - Finance Analysts Rajeev Jashnani - UBS Presentation Rajeev Jashnani - UBS Hi, good morning, everyone. Thanks for participating in the UBS Healthcare Con...

Mayo Clinic, Cancer Genetics Form Diagnostics JV

Mayo Clinic, Cancer Genetics Form Diagnostics Venture

Executive Leadership Team Brings Decades of Entrepreneurial, Manufacturing and Innovation Success to Biozoom

KASSEL, Germany, May 22, 2013 /PRNewswire/ -- Biozoom has created the world's first portable, handheld consumer device to use reflection spectroscopy for real-time diagnostics in humans. A technological breakthrough that some describe as a disruptive technology for the multi-billion dollar health and wellness market, the Biozoom scanner instantly and non-invasively measures certain biomarkers̵...

LipoScience's Vantera® Clinical Analyzer To Provide Hospitals And Physicians With Lipoprotein Analysis For Cardiovascular Disease Management

RALEIGH, N.C., May 22, 2013 /PRNewswire/ -- LipoScience, Inc.,  (NASDAQ:  LPDX) a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care, today announced availability of NMR lipoprotein particle testing using the Vantera® Clinical Analyzer through Mayo Medical Laboratories. NMR lipoprotein...

Abbott to Present at Deutsche Bank 38th Annual Health Care Conference

ABBOTT PARK, Ill., May 22, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) will participate in the Deutsche Bank 38th Annual Health Care Conference on Wednesday, May 29, 2013. Thomas C. Freyman, executive vice president, finance and chief financial officer, and Scott White, senior vice president, international nutrition, will present at 1:10 p.m. Central time. A live audio webcast will be accessi...

Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference

PHILADELPHIA and REHOVOT, Israel, May 22, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that Kenneth A. Berlin, President and Chief Executive Officer of Rosetta Genomics, will deliver a corporate update at the Jefferies 2013 Healthcare Conference taking place from June 3-6, 2013 in New York City.&...

Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures

CAMBRIDGE, Mass., May 22, 2013 /PRNewswire/ -- Flagship Ventures, a leading venture capital and venture creation firm focused on healthcare and sustainability, today announced the appointment of Stephane Bancel as a Senior Partner. In this role, Mr. Bancel will provide strategic counsel and support to portfolio companies. In addition to working closely with companies in the Flagship portfoli...

Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team

Express Diagnostics’ Australian and New Zealand distributor of DrugCheck® onsite testing devices, Royal Medical Supplies, has signed an agreement to sponsor V8 Supercar team Erebus Motorsport. The agreement involves each car of the team displaying the Royal Medical logo in Australian racing events. Blue Earth, MN (PRWEB) May 22, 2013 Express Diagnostics Int’l, Inc. (EDI), and Royal Medic...

Industry Leading Test Laboratory, BioScience Laboratories, Inc. Concludes Phase 1 Safety Evaluations in 12 Weeks, Exceeds Market Value, and Timeline, Again

BioScience Laboratories, Inc. Clinical Laboratory has again exceeded market standards for Phase 1 Dermatological Safety Studies for an IND submission. Phase I Dermatological Safety Studies represent a critical transition into the human model for every IND and ANDA submission. Bozeman, MT (PRWEB) May 22, 2013 BioScience Laboratories clinical laboratory has again exceeded market standards for Phase...

UK-Norwegian collaboration aims to develop a new living skin equivalent testing model for testing inflammatory responses.

Epistem, the UK biotechnology and personalized medicine company with expertise in skin biology and delivery of dermatological testing services, and ScandiDerma, a Norwegian company with expertise in developing new dermatological ingredients from biom...

Prolor Biotech Buyout: Is The Opko Bear Case Now Dead?

By Daniel Lauchheimer:Last month, Opko Health (OPK) bought PROLOR Biotech (PBTH). Shareholders of PBTH will receive just under 1 share of OPK for each share of PBTH. Considering this even trade, current shareholders of PBTH will need to decide if they want to hold onto the OPK shares they receive, or deploy capital somewhere else. In this article I will take a close look at OPK, and try to assess...

Roche presents new, fully automated lab solution at Europe's largest diagnostics conference

Roche announced today at the IFCC Euromedlab in Milan, Italy that it will soon introduce the cobas 8100 automated workflow series, a new solution for use in diagnostic laboratories. cobas 8100 automates numerous routine diagnostic laboratory tasks, w...

A Novel Human Antibody for Deploying CH2 Based Therapeutics

The subject invention describes a novel human antibody (anti-CH2 Fab m01m1) which could be used safely in vitro and in vivo for the detection of CH2 (Fc and IgG as well). More specifically, anti-CH2 Fab m01m1 recognizes a conformational epitope on CH2 so it can be used to monitor the conformational changes when CH2 is modified and mutated, as well as to select proper folded isolated CH2 domains. T...

FDA approves Hologic's new C-View 2D imaging software

The US Food and Drug Administration (FDA) has approved the use of diagnostics provider Hologic's new C-View 2D imaging software.

Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo

Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld

An increase in the number of infertile women seeking treatment and substantial government funding are driving demand for fertility treatment. For this reason, industry research firm IBISWorld has added a report on the Fertility Clinics in Australia to its growing industry report collection. Melbourne, Australia (PRWEB) May 22, 2013 About one in six Australian couples suffer infertility, which has...

Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease

A new study appearing in the current issue of STEM CELLS Translational Medicine indicates that stem cells harvested from fat (adipose) are more potent than those collected from bone marrow in helping to modulate the body’s immune system. Durham, NC (PRWEB) May 21, 2013 A new study appearing in the current issue of STEM CELLS Translational Medicine indicates that stem cells harvested from fat (a...

New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development

NEW YORK, May 21, 2013 /PRNewswire/ -- The Lindsley F. Kimball Research Institute of the New York Blood Center announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.  Dr. Sara Lustigman, Head of the Laboratory of Molecular Parasitology will pursue an innovative global health and development research project, tit...

Biodesix to Announce Results of VeriStrat® Biomarker Study

Independent Phase III Data to Be Presented at the 2013 ASCO Annual Meeting Biodesix, Inc., announced that final results of the first completed biomarker-stratified, validation study in oncology will be presented at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31st – June 4th, 2013. The Randomized Pr...